86 related articles for article (PubMed ID: 34190542)
1. Py-Macrodipa: A Janus Chelator Capable of Binding Medicinally Relevant Rare-Earth Radiometals of Disparate Sizes.
Hu A; Aluicio-Sarduy E; Brown V; MacMillan SN; Becker KV; Barnhart TE; Radchenko V; Ramogida CF; Engle JW; Wilson JJ
J Am Chem Soc; 2021 Jul; 143(27):10429-10440. PubMed ID: 34190542
[TBL] [Abstract][Full Text] [Related]
2. Chelating Rare-Earth Metals (Ln
Hu A; Simms ME; Kertesz V; Wilson JJ; Thiele NA
Inorg Chem; 2022 Aug; 61(32):12847-12855. PubMed ID: 35914099
[TBL] [Abstract][Full Text] [Related]
3. Macrocyclic Ligands with an Unprecedented Size-Selectivity Pattern for the Lanthanide Ions.
Hu A; MacMillan SN; Wilson JJ
J Am Chem Soc; 2020 Aug; 142(31):13500-13506. PubMed ID: 32697907
[TBL] [Abstract][Full Text] [Related]
4. Equilibrium Thermodynamics of Macropa Complexes with Selected Metal Isotopes of Radiopharmaceutical Interest.
Blei MK; Waurick L; Reissig F; Kopka K; Stumpf T; Drobot B; Kretzschmar J; Mamat C
Inorg Chem; 2023 Dec; 62(50):20699-20709. PubMed ID: 37702665
[TBL] [Abstract][Full Text] [Related]
5. Bispidine Chelators for Radiopharmaceutical Applications with Lanthanide, Actinide, and Main Group Metal Ions.
Kopp I; Cieslik P; Anger K; Josephy T; Neupert L; Velmurugan G; Gast M; Wadepohl H; Brühlmann SA; Walther M; Kopka K; Bachmann M; Stephan H; Kubeil M; Comba P
Inorg Chem; 2023 Dec; 62(50):20754-20768. PubMed ID: 37707798
[TBL] [Abstract][Full Text] [Related]
6. Macrocyclic chelator assembled RGD multimers for tumor targeting.
Zhang X; Liu H; Miao Z; Kimura R; Fan F; Cheng Z
Bioorg Med Chem Lett; 2011 Jun; 21(11):3423-6. PubMed ID: 21524578
[TBL] [Abstract][Full Text] [Related]
7. Reining in Radium for Nuclear Medicine: Extra-Large Chelator Development for an Extra-Large Ion.
Simms ME; Sibley MM; Driscoll DM; Kertesz V; Damron JT; Ivanov AS; White FD; Thiele NA
Inorg Chem; 2023 Dec; 62(50):20834-20843. PubMed ID: 37811965
[TBL] [Abstract][Full Text] [Related]
8. Comparative Study of a Decadentate Acyclic Chelate, HOPO-O
Carbo-Bague I; Li C; McNeil BL; Gao Y; McDonagh AW; Van de Voorde M; Ooms M; Kunz P; Yang H; Radchenko V; Schreckenbach G; Ramogida CF
Inorg Chem; 2023 Dec; 62(50):20549-20566. PubMed ID: 36608341
[TBL] [Abstract][Full Text] [Related]
9. EHDTA: a green approach to efficient Ln
Travagin F; Macchia ML; Grell T; Bodnár J; Baranyai Z; Artizzu F; Botta M; Giovenzana GB
Dalton Trans; 2024 Jan; 53(4):1779-1793. PubMed ID: 38170858
[TBL] [Abstract][Full Text] [Related]
10. Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.
Zeglis BM; Houghton JL; Evans MJ; Viola-Villegas N; Lewis JS
Inorg Chem; 2014 Feb; 53(4):1880-99. PubMed ID: 24313747
[TBL] [Abstract][Full Text] [Related]
11. Transition and Post-Transition Radiometals for PET Imaging and Radiotherapy.
Ramogida C; Price E
Methods Mol Biol; 2024; 2729():65-101. PubMed ID: 38006492
[TBL] [Abstract][Full Text] [Related]
12. Towards the stable chelation of radium for biomedical applications with an 18-membered macrocyclic ligand.
Abou DS; Thiele NA; Gutsche NT; Villmer A; Zhang H; Woods JJ; Baidoo KE; Escorcia FE; Wilson JJ; Thorek DLJ
Chem Sci; 2021 Jan; 12(10):3733-3742. PubMed ID: 34163647
[TBL] [Abstract][Full Text] [Related]
13. The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality?
Duatti A
EJNMMI Radiopharm Chem; 2023 Aug; 8(1):17. PubMed ID: 37535275
[TBL] [Abstract][Full Text] [Related]
14. Establishing Cost-Effective Computational Models for the Prediction of Lanthanoid Binding in [Ln(NO
Peterson CC; Penchoff DA; Auxier JD; Hall HL
ACS Omega; 2019 Jan; 4(1):1375-1385. PubMed ID: 31459405
[TBL] [Abstract][Full Text] [Related]
15. Mausolates†: Large-Cavity Chelates with Potential as Delivery Vehicles in Nuclear Medicine.
Berg D; Ackroyd AJ; Gajecki L; Gogoulis AT; Smart JF; Oliver AG; McIndoe JS
Chemistry; 2024 May; ():e202401987. PubMed ID: 38820179
[TBL] [Abstract][Full Text] [Related]
16. Construction of the Bioconjugate Py-Macrodipa-PSMA and Its In Vivo Investigations with Large
Hu A; Martin KE; Śmiłowicz D; Aluicio-Sarduy E; Cingoranelli SJ; Lapi SE; Engle JW; Boros E; Wilson JJ
Eur J Inorg Chem; 2023 Dec; 26(35):. PubMed ID: 38495596
[TBL] [Abstract][Full Text] [Related]
17. Targeted Alpha Therapy: All We Need to Know about
Jalloul W; Ghizdovat V; Stolniceanu CR; Ionescu T; Grierosu IC; Pavaleanu I; Moscalu M; Stefanescu C
Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139806
[TBL] [Abstract][Full Text] [Related]
18. Radiolabeling and
Martin KE; Mattocks JA; Śmiłowicz D; Aluicio-Sarduy E; Whetter JN; Engle JW; Cotruvo JA; Boros E
RSC Chem Biol; 2023 Jun; 4(6):414-421. PubMed ID: 37292057
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of
Bobba KN; Bidkar AP; Meher N; Fong C; Wadhwa A; Dhrona S; Sorlin A; Bidlingmaier S; Shuere B; He J; Wilson DM; Liu B; Seo Y; VanBrocklin HF; Flavell RR
J Nucl Med; 2023 Jul; 64(7):1076-1082. PubMed ID: 37201957
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
